Skip navigation

CBI’s 3rd Annual Bio/Pharmaceutical and Medical Device Product Launch and Market Access Congress

July 19-20, 2012

Available for $298.00

Hear from 15+ Bio/Pharmaceutical and Medical Device Leaders involved in Commercial Strategy

This July, industry experts convene to discuss strategies and solutions to obtain and maintain commercial success in light of prevailing external trends including generic competition, healthcare reform and shifts in healthcare delivery.  Attendees hear case studies from large and small bio/pharmaceutical and device peers focused on new product planning, market development, launch execution and lifecycle management that increases market share.  Examine pressures impacting how payers, HCPs and patients make decisions about products.

Marketing, Brand and Reimbursement Professionals Cannot Miss:

  • Exploration of commercial models that affect launch success and ROI
  • Marketing and sales strategies to support established brands
  • VP Panel illuminating how reimbursement and regulatory trends should impact your product-level strategy
  • Strategies to integrate launch planning across global affiliates
  • Market development techniques specific to product type (e.g. orphan) and community
  • Case studies from Genzyme, Novartis, Cordis Corporation, ViroPharma and others

This conference is tri-located with CBI’s 7th Annual Rare Disease and Orphan Drug Leadership Congress and CBI’s 5th Annual Congress on Expanded Access Programs for Investigational or Pre-Launch Drugs.

This conference is a part of CBI’s 3-Day Access World.

Access World brings together the delegations of the annual Congresses on Rare Disease, Access Programs for Investigational and Pre-Launch Drugs, and Product Launch and Market Access.

To take full advantage of Access World, register for one of the annual 2-day congresses and choose which program’s additional day of content you’d like to attend at the special Access World rate.  See Pricing for details.

 


 

About our Silver Sponsor: Campbell Alliance

Campbell Alliance is the Consulting business segment of inVentiv Health, a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm’s clients include all of the world’s top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Pricing and Market Access, Medical Affairs and Sales. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta and Zug, Switzerland, the firm serves clients throughout North America, Europe and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.